Clinical Management of Skin Cancer: From Pathology Advances to Techniques Applications

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Dermatology".

Deadline for manuscript submissions: 15 January 2025 | Viewed by 474

Special Issue Editor


E-Mail Website
Guest Editor
St. John’s Dermatopathology, Tissue Sciences, Synnovis Analytics, St. Thomas’ Hospital, London, UK
Interests: immunocytochemistry; Mohs micrographic surgery; alopecia; malignant melanoma; cutaneous lymphoma

Special Issue Information

Dear Colleagues,

Skin cancer is a global threat with incidence rates set to rise steadily over the next few decades. The most effective treatments for the majority of both melanoma and non-melanoma skin lesions still largely rely on early detection with surgical removal. The investigation and treatment of skin cancers focus on strategies such as surgery, radiotherapy, chemotherapy, photothermal therapy, and combination therapy. Recently, there has been a rise in the evaluation of molecular targets that are implicated in skin cancer growth and metastasis. In this Special Issue, we seek to highlight the importance of continued expansion in the field of translational and clinical research to provide better insights into single and combined therapies for treating skin cancer. We welcome authors to submit papers on the clinical management of skin cancer through advanced technical applications with an emphasis on pathological advances in our understanding of skin cancer biology.

Dr. Guy Orchard
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • skin cancer
  • surgery
  • chemotherapy
  • radiotherapy
  • photothermal therapy
  • combination therapy
  • molecular target strategies

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

21 pages, 1886 KiB  
Review
One-Stop Shop: Diagnosis and Treatment of Basal Cell Carcinoma in One Step
by Kristina Fünfer, Marco Mozaffari, Oliver Mayer, Sophia Schlingmann, Julia Welzel and Sandra Schuh
J. Clin. Med. 2024, 13(13), 3830; https://doi.org/10.3390/jcm13133830 - 29 Jun 2024
Viewed by 329
Abstract
Monitoring the tumor margins of basal cell carcinomas is still a challenge in everyday clinical practice. Usually, the clinical margins of the tumor are marked by the naked eye or, even better, with dermoscopy before surgery and then examined in detail after the [...] Read more.
Monitoring the tumor margins of basal cell carcinomas is still a challenge in everyday clinical practice. Usually, the clinical margins of the tumor are marked by the naked eye or, even better, with dermoscopy before surgery and then examined in detail after the operation using histological examination. In order to achieve tumor freedom, several surgical steps are sometimes necessary, meaning that patients spend longer periods in hospital and the healthcare system is burdened more as a result. One way to improve this is the one-stop shop method, which requires precise diagnostics and margin marking before and during surgery so that tumor freedom can be achieved after just one surgery. For this reason, the current status of the diagnosis and treatment of basal cell carcinomas before and after surgery is to be examined following extensive literature research using devices and methods that have already been tested in order to determine how a simplified process of tumor margin control of basal cell carcinomas can be made possible both in vivo and ex vivo. Full article
Show Figures

Figure 1

Back to TopTop